Autologous Bone Marrow Mononuclear Cells Therapy in Diabetic Lower Limb Ischemia

NCT01937416 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Lower Limb Ischemia

Interventions

BIOLOGICAL: autologous bone marrow mononuclear cells

Sponsor

Hebei Medical University